Lv52
1210 积分 2024-03-22 加入
Designing acute kidney injury clinical trials
1天前
已完结
Re: Fred Saad, Noel W. Clarke, Mototsugu Oya, et al. Olaparib plus Abiraterone Versus Placebo plus Abiraterone in Metastatic Castration-resistant Prostate Cancer (PROpel): Final Prespecified Overall Survival Results of a Randomised, Double-blind, Phase 3 Trial. Lancet Oncol 2023;24:1094–108
1天前
已完结
Keap1-independent Nrf2 regulation: a novel therapeutic target for treating kidney disease
25天前
已完结
Tumor Microenvironment‐Activatable Metal‐Phenolic Nanoformulations for Ultrasound‐Boosted Ferroptosis through Triple Regulatory Pathways
25天前
已完结
RGS19 converts iron deprivation stress into a growth-inhibitory signal
1个月前
已完结
Engineered Macrophage Membrane-Coated Nanoparticles Attenuate Calcium Oxalate Nephrocalcinosis-Induced Kidney Injury by Reducing Oxidative Stress and Pyroptosis
1个月前
已完结
High-Throughput Screening Strategy and Metal–Organic Framework-Based Multifunctional Controlled-Release Nanomaterial for Osteoarthritis Therapy
1个月前
已完结
Engineered Molybdenum Disulfide Nanosheets as Scavengers Against Oxidative Stress and Inhibit Ferroptosis to Alleviate Acute Kidney Injury
1个月前
已完结
Biomimetic reactive oxygen/nitrogen nanoscavengers inhibit “ferroptosis storm” and modulate immune targeting for acute kidney injury
1个月前
已完结
NETosis and kidney disease: what do we know?
1个月前
已完结
皖公网安备34019202002308
